Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Inhibrx Biosciences, Inc. | Chief Executive Officer, Director | Common Stock | 706K | $12.1M | $17.13 | Sep 16, 2024 | By the Lappe Family Trust |
Inhibrx Biosciences, Inc. | Chief Executive Officer, Director | Common Stock | 165K | $2.83M | $17.13 | Sep 12, 2024 | By Lappe Descendants' Trust |
Inhibrx Biosciences, Inc. | Chief Executive Officer, Director | Common Stock | 54.9K | $940K | $17.13 | Sep 12, 2024 | The Mark Paul Lappe Roth IRA |
Inhibrx, Inc. | Chief Executive Officer, Director | Common Stock | 0 | $0 | $30.00 | May 30, 2024 | By the Lappe Family Trust |
Inhibrx, Inc. | Chief Executive Officer, Director | Common Stock | 0 | $0 | $30.00 | May 30, 2024 | By trust |
Inhibrx, Inc. | Chief Executive Officer, Director | Common Stock | 0 | $0 | $30.00 | May 30, 2024 | The Mark Paul Lappe Roth IRA |
Inhibrx, Inc. | Chief Executive Officer, Director | Stock Option (right to buy) | 0 | $0 | $34.12 | May 30, 2024 | Direct |
Inhibrx Biosciences, Inc. | Chief Executive Officer, Director | Stock Option (right to buy) | 300K | May 30, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
INBX | Inhibrx Biosciences, Inc. | Sep 12, 2024 | 2 | $629K | 4 | Sep 16, 2024 | Chief Executive Officer, Director |
INBX | Inhibrx Biosciences, Inc. | Sep 6, 2024 | 3 | $671K | 4 | Sep 10, 2024 | Chief Executive Officer, Director |
INBX | Inhibrx Biosciences, Inc. | Aug 29, 2024 | 4 | $597K | 4 | Sep 3, 2024 | Chief Executive Officer, Director |
INBX | Inhibrx Biosciences, Inc. | Aug 20, 2024 | 2 | $518K | 4 | Aug 22, 2024 | Chief Executive Officer, Director |
INBX | Inhibrx, Inc. | May 30, 2024 | 5 | -$91.4M | 4 | May 30, 2024 | Chief Executive Officer, Director |
INXB | Inhibrx Biosciences, Inc. | May 29, 2024 | 4 | $0 | 4 | May 30, 2024 | Chief Executive Officer, Director |
INXB | Inhibrx Biosciences, Inc. | May 24, 2024 | 0 | $0 | 3 | May 24, 2024 | Chief Executive Officer, Director |
INBX | Inhibrx, Inc. | Feb 28, 2023 | 1 | -$1.5K | 4 | Mar 1, 2023 | Chief Executive Officer, Director |
INBX | Inhibrx, Inc. | Jan 23, 2023 | 3 | -$661K | 4 | Jan 24, 2023 | Chief Executive Officer, Director |
INBX | Inhibrx, Inc. | Jan 3, 2023 | 1 | $0 | 4 | Jan 3, 2023 | Chief Executive Officer, Director |
INBX | Inhibrx, Inc. | Dec 19, 2022 | 2 | -$664K | 4 | Dec 20, 2022 | Chief Executive Officer, Director |
INBX | Inhibrx, Inc. | Nov 17, 2022 | 7 | -$725K | 4 | Nov 18, 2022 | Chief Executive Officer, Director |
INBX | Inhibrx, Inc. | Oct 17, 2022 | 4 | -$769K | 4 | Oct 18, 2022 | Chief Executive Officer, Director |